Get the content you want anytime you want.

Latest News From Contagion® Live

Latest News

FDA Issues Complete Response Letter for Iclaprim
The FDA has granted issued a Complete Response Letter to Motif Bio regarding the New Drug Approval for iclaprim.
FDA Approves Triclabendazole for Treatment of Fascioliasis
The FDA has approved triclabendazole (Egaten) for the treatment of fascioliasis, a neglected tropical disease in patients 6 years of age and older
Venezuela's Resurgence of Vaccine-Preventable Diseases
As political and economic turmoil envelop the nation, crumbling health care infrastructure has reintroduced vaccine-preventable diseases and providers have limited resources to treat the infections.
Inhalation Formulation of Itraconazole Receives IND Authorization From FDA
The FDA has authorized a phase 2 study of PUR1900, an inhaled formulation of itraconazole, for the treatment of allergic bronchopulmonary aspergillosis.
Ending the HIV Epidemic by 2030—Is Trump's SOTU Promise Feasible? Public Health Watch
The bold promise in last week’s State of the Union address is achievable, but may mean keeping the Affordable Care Act.
Omadacycline: A New Player for Team Tetracycline
An oral alternative for patients requiring broad-spectrum therapy in this era of resistance. 
REACH Study to Evaluate PrEP and Vaginal Ring for HIV Prevention
The NIH has announced that a trial evaluating the safety of and adherence to a vaginal ring containing dapivirine and oral tablets for PrEP is now underway in southern Africa.
Single-Dose Tafenoquine Could Prevent Relapse of <i>P vivax</i> Malaria
Single-dose tafenoquine shows promise for the radical cure of P vivax malaria, according to two new studies published in the New England Journal of Medicine.
Big advances in treatment can